Lobet 100mg Tablet

Lobet 100mg Tablet

Therapeutic Class:
Get Quote

Lobet 100mg Tablet is a medicine used for treating high blood pressure (hypertension) and heart-related chest pain (angina). It is also effective for treating high blood pressure in pregnancy. It lowers blood pressure and thus helps in preventing future stroke and heart attack.

Lobet 100mg Tablet should be taken with food. This medicine may be used alone or in combination with other medicines. Use it along with a healthy diet, regular exercise, and without smoking for best results. Since it can cause serious withdrawal effects, it should not be stopped abruptly.

Some common side effects of this medicine include hypersensitivity (rash, pruritus, angioedema), tingling sensation in scalp, heart failure, increased liver function tests, difficulty in utrination, erectile dysfunction, and drug fever. These side effects usually get better with time, however, if they persist or get worse, let your doctor know.

Salt Composition: Labetalol
Strength: (100mg)
Pack Size: 10.0 tablets in 1 strip
Uses: Angina (heart-related chest pain) Hypertension (high blood pressure) Prevention of heart attack and stroke
Table Header
Salt Composition
Pack Size
10.0 tablets in 1 strip
Angina (heart-related chest pain) Hypertension (high blood pressure) Prevention of heart attack and stroke
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Lobet 100mg Tablet which is also known as Labetalol and Manufactured by Samarth Life Sciences Pvt Ltd. It is available in strength of (100mg) is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed